Literature DB >> 14602140

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression.

M Beau-Faller1, M P Gaub, A Schneider, E Guérin, Nicolas Meyer, X Ducrocq, G Massard, B Gasser, R Kessler, E Weitzenblum, J M Wihlm, E Quoix, P Oudet.   

Abstract

Fibroblast growth factors (FGF), hepatocyte growth factor (HGF) and their receptors, FGFR and c-Met, are essential components of the regulatory networks between the epithelium and mesenchyme in embryonic lung, but their respective roles in tumour growth are not clear. We performed allelotyping at loci containing the candidate genes FGFR-1-2-3-4, FGF-1-2-7-10, c-Met and HGF in 36 non-small cell lung cancer (NSCLC) (20 squamous-cell carcinomas (SQC) and 16 adenocarcinomas (ADC)), by surrounding each locus with two microsatellites (MS), as close as possible to the genes of interest. Unexpectedly, SQC and ADC were frequently altered at all of these loci, and SQC showed more simultaneously altered loci. In ADC, alterations at the 15q13-22 locus (FGF7 candidate gene) were significantly more frequent. Thus, these loci showed different patterns of molecular alterations between SQC and ADC. Finally, alterations at loci containing FGFR and HGF candidate genes were inversely correlated to the lymph node status in SQC and ADC, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602140     DOI: 10.1016/s0959-8049(03)00623-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.

Authors:  Deping Zhao; Yi Lu; Chenlu Yang; Xiao Zhou; Zhifei Xu
Journal:  Tumour Biol       Date:  2015-01-08

2.  Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.

Authors:  Yi-Ran Cai; Hai-Qing Zhang; Zong-DE Zhang; Jing Mu; Zi-Hui Li
Journal:  Oncol Lett       Date:  2010-12-23       Impact factor: 2.967

3.  Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.

Authors:  Ravi Salgia
Journal:  Cancer Med       Date:  2014-04-08       Impact factor: 4.452

4.  Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.

Authors:  A Matakidou; R El Galta; M F Rudd; E L Webb; H Bridle; T Eisen; R S Houlston
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

5.  Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report.

Authors:  Martin Svaton; Tomas Vanecek; Petr Mukensnabl; Jan Baxa; Gabriela Krakorova; Jiri Blazek; Milos Pesek
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.